NExTNet
Company

Last deal

$1.3M

Amount

Seed

Stage

31.05.2023

Date

1

all rounds

$1.3M

Total amount

General

About Company
NExTNet is developing an operating system for modern biotech and pharma.

Industry

Sector :

Subsector :

Keywords :

founded date

2021

Number of employees

Company Type

For Profit

Last funding type

Seed

IPO status

Private

Description

The company has created Sapiens, a natural language-based explainable AI platform that allows domain experts to ask and answer complex questions without needing to know coding, querying languages, or statistics. Sapiens integrates knowledge from various data sources, such as sequencing, expression, and text, to help experts understand the underlying molecular mechanisms for drug development. NExTNet's goal is to organize and integrate the world's biomedical knowledge and make it accessible. The company uses breakthroughs in natural language and explainable AI, software, graph databases, and human-in-the-loop reinforcement learning to build Sapiens, a digital infrastructure that enables faster knowledge discovery and decision-making. Sapiens allows users to conduct semantic and conceptual searches, visualize and navigate knowledge connections in 3D, and collaborate with others to generate hypotheses and make informed decisions. Biotech and biopharmaceutical companies, academic labs, and cancer centers are among the growing number of organizations using Sapiens to discover new insights for free.
Contacts